PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 1978Circulation499 citations

The role of the exercise test in the evaluation of patients for ischemic heart disease.

View Full Paper
JMJ F McNeerJMJames R. MargolisKLK L Lee

Key Points

  • The research examines the importance of exercise testing in diagnosing and predicting outcomes for ischemic heart disease patients.
  • Cohort study of 1472 patients undergoing exercise stress testing and coronary angiography within six weeks.
  • Assessment of exercise test parameters relating to coronary artery disease severity and prognosis.
  • Identification of low and high-risk subgroups based on exercise test results and survival rates.
  • Over 97% of patients with positive exercise tests at Stage I or II had significant coronary artery disease, with 60% having three vessel disease.
  • Patients achieving Stage IV or greater with negative ST-segment response had under 15% prevalence of three vessel disease and <1% left main disease.
  • Identified a 75% low-risk subgroup with over 99% twelve-month survival and an 11% high-risk subgroup with under 85% twelve-month survival.

Abstract

A cohort of 1472 patients who underwent both exercise stress testing and coronary angiography within six weeks was examined. The data indicated that a combination of exercise parameters is both diagnostically and prognostically important. Almost all patients (greater than 97%) who had positive exercise tests at Stage I or Stage II had significant coronary artery disease. More than half of these (greater than 60%) had three vessel disease and over 25% had significant narrowing (greater than 50%) of the left main coronary artery. Patients who achieved Stage IV or greater exercise durations with either negative or indeterminate ST-segment response had less than a 15% prevalence of three vessel disease and less than a 1% prevalence of left main coronary artery disease. A low risk subgroup (75% of all non-operated patients) was identified with a twelve month survival greater than 99%. A high risk subgroup (11% of all nonoperated patients) was identified with a twelve month survival of less than 85%. The exercise test is a noninvasive, reproducible method to assess the presence and extent of anatomic disease and the prognosis when significant disease has been defined. It should be used in conjunction with other noninvasive tests to determine optimal management in patients evaluated for ischemic heart disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

McNeer et al. (1978) studied this question.

synapsesocial.com/papers/6a0f07c61c5e2d2319fa40c3https://doi.org/10.1161/01.cir.57.1.64
Ask AI
Helpful
Bookmark
Share
View Full Paper